Company profile
SelectION company profile
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases and selecting cancer indications by targeting autoreactive, chronically activated T cells. It has established a technology platform to develop potent and highly selective peptide blockers for ion channels involved in various diseases. Its platform enables to optimize the target selectivity, providing the opportunity to develop drugs with significantly improved efficacy and safety profiles.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2017-01-01, Year
Headquarters
- Headquarters
- Wonewoc, Wisconsin, United States
- Postal code
- 92101
- Country code
- US
- Continent
- North America